Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites

Clinical trial NCT06553456 · COMPLETED

Trial details

NCT number: NCT06553456
Sponsor: Protgen Ltd
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Cirrhotic Ascites

Start date: 2024-08-19
Primary completion: 2025-05-14
Enrollment: 390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.